OLIGONUCLEOTIDES OR THEIR FUNCTIONAL HOMOLOGUES, COMPOSITION CONTAINING THEM AND METHOD OF TREATING B-CELL TUMOUR Russian patent published in 2011 - IPC A61K31/7088 A61K31/573 A61P35/00 A61P35/02 

Abstract RU 2413519 C2

FIELD: medicine.

SUBSTANCE: declared group of inventions refers to medicine, namely to oncology, and can be used for treating B-cell tumour in a mammal. The method of treating B-cell tumour consists in administering a therapeutically effective amount of a pharmaceutical composition containing oligonucleotide having any of sequences SEQ ID NO: 1-9. Also, there are offered a method for inducing cell apoptosis of B-cell tumour, a method for increasing CD40 cell expression of B-cell tumour, and a method for inducing IL-10 cell production of B-cell tumour by contacting said cells of B-cell tumour with the composition containing oligonucleotide having any of sequences SEQ ID NO: 1-9. Besides, offered is the pharmaceutical composition containing (1) oligonucleotide having any of sequences SEQ ID NO: 1-9, and (2) a B-cell tumour agent.

EFFECT: invention provides effective therapy of B-cell tumour due to inducing tumour cell apoptosis which is caused by increasing CD40 cell expression of B-cell tumour and stimulated IL-10 cell production of B-cell tumour.

21 cl, 3 dwg, 5 tbl, 9 ex

Similar patents RU2413519C2

Title Year Author Number
OLIGONUCLEOTIDE OR ITS FUNCTIONAL HOMOLOG, COMPOSITION CONTAINING IT AND METHOD OF TREATING OF B-LYMPHOID NEOPLASM 2006
  • Van Li-In
  • Bao Mu-Shehn
  • Juj Jun-Li
RU2409672C2
TREATMENT OF B-CELLULAR MALIGNANT TUMORS USING ANTI-CD40L ANTIBODIES IN COMBINATION WITH ANTI-CD20 ANTIBODIES AND/OR BY CHEMOTHERAPY AND RADIOTHERAPY 2000
  • Khanna Nabil
  • Kharikharan Kandasami
RU2305561C2
DECREASING B-CELL COUNT WITH USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES 2006
  • Grosmehjr Laura S'Ju
  • Khajdehn-Ledbehttehr Marta S'Juzan
  • Ledbehttehr Dzheffri A.
  • Tompson Piter Armstrong
  • Sajmon Sandi Aleksander
  • Brehdi Uill'Jam
RU2423381C2
CHIMERIC ANTIGENIC RECEPTORS AIMED AT ANTIGEN OF AGING OF B-CELLS 2016
  • Kuo Trejsi Chia-Chien
  • Chaparro Ridzhers Khaver Fernando
  • Sasu Barbra Dzhonson
  • Galetto Roman
  • Boldazhipur Bizhan Andre
  • Sommer Sezar Adolfo
  • Van Blerkom Tomas Dzhon
  • Pertel Tomas Charlz
  • Radzhpal Arvind
  • Dushato Filipp
  • Zhuillera Aleksandr
  • Valton Zhyulen
RU2706582C2
ANTI-CD40-ANTIBODIES AND METHODS OF APPLICATION 2012
  • Chzhan Yunke
  • Yuj Go-Lyan
  • Chzhu Vejmin
RU2609647C2
USING ANTI-CD40-ANTIBODIES 2008
  • Lukman Mokhammad
  • Van Junjuj
  • Kantak Sima
  • Khsu Ssuchehn Tsz.
  • Mirza Amer M.
RU2491095C2
COMPOSITIONS AND METHODS OF IMMUNOTHERAPY 2014
  • Brentdzhens Rener Dzh.
  • Dzhekson Kholli Dzh.
RU2680010C2
COMBINATION OF CD19 ANTIBODY WITH BCL-2 INHIBITOR AND ITS APPLICATION METHODS 2017
  • Endell Jan
  • Petropoulos Konstantin
  • Kelemen Peter
  • Boxhammer Rainer
  • Ruckert Markus
RU2756405C2
ANTIBODIES AGAINST CCR7 RECEPTOR FOR CANCER TREATMENT 2006
  • Mun'Os Kall'Ekha Sesilija
  • Al'Fonso Peres Manuehl' Khesus
  • Lopes Khiral' Sonia
RU2404808C2
METHODS FOR IMMUNOTHERAPY WITH CHIMERIC ANTIGEN RECEPTOR IN COMBINATION WITH 4-1BB AGONIST 2019
  • Go, William Y.
  • Woolfson, Adrian
RU2788524C2

RU 2 413 519 C2

Authors

Van Li-In

Bao Mu-Shehn

Juj Jun-Li

Dates

2011-03-10Published

2006-02-13Filed